176 related articles for article (PubMed ID: 32725375)
1. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
[TBL] [Abstract][Full Text] [Related]
2. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
Diachinsky M; Tran T; Jupp J; McKinnon K
J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
Heisler RD; Kelly JJ; Abedinzadegan Abdi S; Hawker JL; Fong LG; Quon JL; Rioux JZ; Jupp JC
Support Care Cancer; 2022 Feb; 30(2):1273-1281. PubMed ID: 34471970
[TBL] [Abstract][Full Text] [Related]
4. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.
Roy AM; Lei M; Lou U
J Oncol Pharm Pract; 2019 Dec; 25(8):1860-1866. PubMed ID: 30636529
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
[TBL] [Abstract][Full Text] [Related]
7. Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage.
Visage R; Kaiser N; Williams M; Kim A
J Pediatr Hematol Oncol; 2019 Jul; 41(5):371-375. PubMed ID: 30475303
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
Kramer E; Filtz M; Pace M
J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.
Perkey CL; Flynn LA; Lentz K; Butler S
J Oncol Pharm Pract; 2023 Jan; 29(1):119-124. PubMed ID: 34931924
[TBL] [Abstract][Full Text] [Related]
10. Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
Alsdorf WH; Karagiannis P; Langebrake C; Bokemeyer C; Frenzel C
Oncologist; 2021 Feb; 26(2):e327-e332. PubMed ID: 33215763
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.
Reed DR; Pierce EJ; Sen JM; Keng MK
Cancer Manag Res; 2019; 11():8065-8072. PubMed ID: 31507329
[TBL] [Abstract][Full Text] [Related]
12. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
Mangum R; Bernhardt MB; Cheng WS; Schafer ES; Berg SL; Foster JH
Pediatr Blood Cancer; 2020 Sep; 67(9):e28334. PubMed ID: 32608575
[TBL] [Abstract][Full Text] [Related]
13. Oral acetazolamide in the assessment of (urine-blood) PCO2.
Alon U; Hellerstein S; Warady BA
Pediatr Nephrol; 1991 May; 5(3):307-11. PubMed ID: 1651097
[TBL] [Abstract][Full Text] [Related]
14. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
[TBL] [Abstract][Full Text] [Related]
15. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
Kintzel PE; Campbell AD; Yost KJ; Brinker BT; Arradaza NV; Frobish D; Wehr AM; O'Rourke TJ
J Oncol Pharm Pract; 2012 Jun; 18(2):239-44. PubMed ID: 22075004
[TBL] [Abstract][Full Text] [Related]
16. Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study.
Khera S; Mahajan D; Barbind K; Dhingra S
Cancer Chemother Pharmacol; 2023 Apr; 91(4):331-336. PubMed ID: 36951972
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of urine alkalinization by oral administration of sodium bicarbonate: a prospective open-label trial.
Cohen B; Laish I; Brosh-Nissimov T; Hoffman A; Katz LH; Braunstein R; Sagi R; Michael G
Am J Emerg Med; 2013 Dec; 31(12):1703-6. PubMed ID: 24055481
[TBL] [Abstract][Full Text] [Related]
18. Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate.
Shamash J; Earl H; Souhami R
Cancer Chemother Pharmacol; 1991; 28(2):150-1. PubMed ID: 2060085
[TBL] [Abstract][Full Text] [Related]
19. pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia.
Rojas de Morales T; Navas R; Viera N; Alvarez CJ; Chaparro N; Griman D
Med Oral Patol Oral Cir Bucal; 2007 Oct; 12(6):E435-9. PubMed ID: 17909509
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.
Raphael KL; Isakova T; Ix JH; Raj DS; Wolf M; Fried LF; Gassman JJ; Kendrick C; Larive B; Flessner MF; Mendley SR; Hostetter TH; Block GA; Li P; Middleton JP; Sprague SM; Wesson DE; Cheung AK
J Am Soc Nephrol; 2020 Jan; 31(1):161-174. PubMed ID: 31848294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
